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Latissimus dorsi (LD) ﬂap;
Round block technique
(Donut Mastopexy
Resection)Abstract Background: Oncoplastic breast surgery is a standard treatment of early breast cancer,
offering a balance between good cosmetic outcome and limited risk of locoregional recurrence, by
enabling proper resection margins.
Aim of study: To present multiple techniques of partial breast reconstruction following the
resection of centrally located breast cancer (CLBC) resection.
Patients and methods: From January 2011 to August 2014, 21 patients underwent central quadran-
tectomy for carcinoma of the central region of the breast. Excisions included the nipple/areola
complex, in most of the cases, down to the pectoralis fascia with a wide safety margin, and proper
axillary management. Oncoplastic approaches included latissimus dorsi ﬂap, inferior pedicle ﬂap,
Melon slice, Grisotti and round block techniques.
Results: Mean age of patients was 49.5 ± 10.61 years. Tumor size ranged from 1.5 to 4.5 cm.
Postoperative pathology revealed a tumor mean safety margin of 2.5 ± 0.83 cm, with positive axil-
lary lymph nodes in 15 (75.0%) patients. Nineteen (95.0%) patients received postoperative breast
radiotherapy, while 9/20 (45.0%) and 3/20 (15.0%) received adjuvant chemotherapy or hormonal
therapy, respectively, and only 8/20 (40.0%) patients received both therapies. During a median fol-
low-up period of 14.89 months, neither local nor distant metastasis, were detected. The postopera-
tive cosmetic result evaluated by the patients was excellent in 6/20 patients (30.0%), good in 11/20
patients (55.0%), fair in 3/20 (15.0%) with neither poor nor bad results, with an overall mean of
4.0 ± 0.5 equivalent to 80% satisfaction.
Conclusion: Multiple oncoplastic breast surgery techniques can be used for the resection of CLBC
with satisfying cosmetic outcomes.
ª 2014 Production and hosting by Elsevier B.V. on behalf of National Cancer Institute, Cairo University.
Open access under CC BY-NC-ND license.Introduction
Oncoplastic breast surgery (OBS), which combines the
concepts of oncologic and plastic surgery, is becoming a
204 A. Moustafa, I. Fakhrnorm-of-practice treatment of early breast cancer, especially in
Western countries [1–6].
There are two fundamentally different approaches for
breast defect management in OBS: (1) volume-displacement
procedures, which combine resection with a variety of different
breast adjacent tissue rearrangements and mammoplasty tech-
niques, reduction (inferior pedicle, and Melon slice techniques)
and reshaping (round-block technique, Grisotti ﬂap, etc.) tech-
niques [7,8], and (2) volume-replacement procedures, which
combine resection with immediate reconstruction by using
loco-regional ﬂaps [9,10]. In all cases, this can be combined
with simultaneous or delayed correction in the contralateral
breast to achieve better symmetry [11].
The volume-displacement procedures were then sub-classi-
ﬁed by Clough et al. [12,13] into two levels: (I) Including exci-
sion of less than 20% of breast volume, without neither skin
excision nor mammoplasty; (II) Including anticipated resection
of 20–50% breast volume, with excision of excess skin required
to reshape the breast based on mammoplasty techniques.
However, volume-replacement procedures are still possible
to use, in small or medium size breasts, even if only 20–50% of
the breast volume is anticipated to be resected [14].
Nevertheless, patients with centrally located breast tumors
(CLBT), who account for 5–20% of breast cancer cases, have
been routinely denied, and for a long time, the opportunity
for breast conservation [15], strikingly, the NSABBP (B06)
undertaken by Fisher and his colleagues [16] and including
1843 patients did not report one single case of central tumor
as candidate for conservative therapy. Moreover, in their retro-
spective analysis of the NSABBP, Fisher et al. [17] reported
11.1% incidence of pathological inﬁltration of the nipple. It is
not until later, when other authors addressed the relation of
pathological NAC involvement to local and distant treatment
failures and most of them reported no effect on local recur-
rence, disease free or overall survival rates, whether mastec-
tomy or breast conservation therapy were carried out [18,19].
Furthermore, when central quadrantectomy was ﬁrst
applied, cosmetic results were not very satisfactory to many
authors [20–23]. It was not before numerous researchers tried
their best that the ﬁrst cosmetically satisfactory results began
to appear, to mention the latissimus dorsi (LD) myocutaneous
ﬂap by Nogushi et al. [24], Calderoli [25], Calderoli and Piat
[26], and the Grisotti [27] ﬂap, followed by many other emerg-
ing techniques, among which, we have chosen a variety to
explore in this study.
Patients and methods
During the period from January 2011 to July 2014, twenty-one
patients with central breast carcinoma were treated with onco-
plastic surgery.
Preoperatively all patients underwent physical examination
of both breasts and axillae as well as bilateral mammograms
and ultrasonography of both breasts. Histopathological diag-
nosis of cancer was made prior to surgery using ultrasound
guided core needle biopsy. The planned procedure was dis-
cussed with patients, and their approval was documented.
Surgical techniques
Tumors present at the retro-areolar region, or encroaching on
it, underwent central quadrantectomy including excision of thenipple/areola complex (NAC) down to the pectoralis fascia
(Fig. 1). Following surgical excision, the breast specimen was
marked with sutures by the surgeon to retain orientation. Sur-
gical margins were determined by macroscopic and histologic
examination of frozen sections of the breast specimens in the
operating room. An adequate safety margin of 1 cm was
always insured.
Breast reconstruction was done using one of the following
techniques
A. Volume-displacement procedures
 Inferior pedicle technique [27] which consists of a key-hole
excision, including the NAC, followed by an inferior
advancement pedicle carrying skin from the inferior pole
of the breast on the upper half of the pedicle. It was applied
in patients with relatively large sagging breasts, (size C or
D) and was accompanied with contralateral inferior pedicle
reduction mammoplasty, if patient wished.
 Grisotti mastopexy technique [28] which consists of central
quadrantectomy with mobilization of an inferior based
comma-shaped ﬂap, with rounded skin island to ﬁll the
gap. This technique was kept for patient with relatively
smaller lesions in moderate size breasts (B).
 Melon slice [10,27] which consists of a central horizontal
elliptical excision, including NAC, with direct closure. It
is a safe, simple, and quick technique, which was used
whenever the central tumor was located in a more superior
or lateral position, in patient with ptotic moderate to large
size breasts (size B or C), convenient for use in co-morbid
patient.
 Round block technique (or Donut Mastopexy Resection)
[11] which consists of the excision of a circumareolar rim
of skin around the NAC, wider at the tumor location, with
direct closure. It was used for smaller lesions, possibly
within the areolar/peri-areolar zones, which are at least
25 mm deep to the NAC, in almost all breast sizes. This
technique, although initially used for lesions in the upper
half of the breast, enabled the excision of a wide subareolar
resection margin for all peri-areolar lesions.
B. Volume-replacement procedures:
 Latissimus dorsi (LD) myocutaneous ﬂap was used to
reconstruct the elliptical horizontal defect of a central quad-
rantectomy, in patients with relatively large tumors in
small-medium (size A or B) sized breasts and minimal pto-
sis, who cannot afford to lose the volume associated with
volume displacement techniques, or who wish to avoid mas-
tectomy.
C. All patients who underwent nipple–areola complex
(NAC) resection were offered, 6–12 months following
radiation therapy, areola and nipple reconstruction by
means of tattooing followed by central de-epithelialized
local ﬂap, respectively.
Patients presenting with radiologically conﬁrmed clinical
axilla, had sentinel lymph node biopsy (SLNB), using patent
blue and/or radiolabelled colloid. Combined intradermal
peri-areolar and peri-tumoral injection techniques was used.
Patients with positive SLNB or radiologically detected lymph
nodes in the axillae received level I and II dissection. Axillary
Fig. 1 Retro-areolar breast cancer of the left breast treated by central quadrantectomy and latissimus dorsi (LD) ﬂap reconstruction: (A)
bilateral preoperative mapping, (B) intra-operative view of LD at donor site, (C) LD side preoperative mapping, (D) three weeks
postoperative view. The result was assessed by the patient as 3/5 (acceptable result) and objectively by 5/10 (average result).
Outcome of different OPs techniques for CLBC 205lymph node dissection (ALND) was completed in whenever
positive one or both axillary lymph nodes levels were
accoutered.
All patients with expected remarkable discrepancy between
the two breasts post excision, were offered the option of,
simultaneous or delayed reduction mammoplasty of the con-
tralateral breast for better symmetry.
Pathological evaluation
All specimens were oriented and subjected to histopathology
and immunohistochemical examination including ER, PR,
Her-2-neu and ki-67. Margins were regarded as negative when
permanent histological examination found no cancer cells
within a distance of 2 mm from excised tissue surface.
Postoperative follow-up
Postoperative clinical follow-up was done at three months
intervals and included palpation of the breast and axilla.
Tumor marker (CA 15-3), mammograms, and ultrasonogra-
phy were done according to the standard protocol. MRI was
done when needed.
Cosmetic outcome
The postoperative esthetic result was evaluated asking the
patients to rate the postoperative cosmetic result and their
degree of satisfaction compared to the preoperative breast
using a ﬁve-point scale (excellent, 5; good, 4; fair, 3; poor, 2;
bad, 1) [29]. Objective assessment of the cosmetic result was
done by two surgeons and a trained nurse, rated on a visual
analog scale from 1 (unacceptable result) to 10 (excellent
result). Evaluation was based on 5 criteria, namely: breast
symmetry, glandular tissue defects, nipple and areola recon-
struction, scar quality and/or retraction, and the resultant
breast shape.
Results
Mean age of patients was 49.5 ± 10.61 years, and the median
was 48 years (range from 32 to 70 years). The different proce-
dures are presented in Table 1. One of the patients from the
latissimus dorsi group had a small contralateral breast lesion,for which she underwent a breast conserving resection type I
(Fig. 1). Only one patient, who underwent resection using infe-
rior pedicle ﬂap, requested a contralateral inferior pedicle
reduction mammoplasty (Fig. 2). All 19 patients who under-
went NAC resection were reluctant to undergo the tattooing
process, 6–12 months following the end to chemo-radiotherapy,
as previously planned.Surgical complications
There were 5/20 (25.0%) postoperative complications. Three
(60.0%) patients with LD reconstruction had back seroma at
the donor site, which was treated by aspiration, while a fourth
(20.0%) patient had partial ﬂap loss. One (20.0%) patient with
inferior pedicle reconstruction had a partial skin dehiscence,
which required secondary sutures. However, only the last 2
(10%) of our patients had a delay in their adjuvant treatment
for four and two weeks, respectively.Pathological results
Pathological evaluation revealed a mean tumor size of
2.9 ± 0.95 cm, with a median of 3 cm (range from 1.5 to
4.5 cm). Tumors were staged as pT1 in 4 (20.0%) and as
pT2 in 16 (80.0%) patients. All surgical safety margins were
negative with a mean of 2.5 ± 0.83 cm and a median of
2.4 cm (range from 0.8 to 4.0 cm). Surgical margins of
2–4 cm were almost always the deep ones, since pectoralis fas-
cia was reached in all resections. Only one patient revealed
positive margin with ductal carcinoma in situ (DCIS), on par-
afﬁn section, although it was negative on frozen section, and
had to be completed to modiﬁed radical mastectomy, with
immediate reconstruction using extended LD ﬂap, conse-
quently, patient was excluded from the study. Eighteen tumors
were invasive duct carcinoma (IDC) (90.0%), while 2 (10.0%)
were invasive lobular carcinoma (ILC), and all, were moder-
ately differentiated (95.0%), except one which was undifferen-
tiated Table 1.
Thirteen (65.0%) patients had positive axillary lymph
nodes, all staged as pN1; while the other 7 (35.0%) where
staged as pN0. Among the last, only one patient presented
with a clinically negative axilla, SLND was done using com-
bined technique, and proved to be negative, and the ALND
was abandoned.
Fig. 2 Retro-areolar breast cancer of the left breast treated by central quadrantectomy and inferior pedicle ﬂap reconstruction on left
side, with contralateral inferior pedicle reduction for symmetrization: (A) preoperative mapping, (B) intra-operative view of de-
epithelialization of the ﬂap, and (C) one month postoperative view. The result was assessed by the patient as 3/5 (good result) and
objectively by 7/10 (good result).
Fig. 3 Retro-areolar breast cancer of the right breast treated by central quadrantectomy and Grisotti technique for reconstruction: (A)
preoperative mapping, (B) intraoperative, and (C) immediate postoperative view (from another patient). The result was assessed by the
patient as 4/5 (good result) and objectively by 6/10 (good result).
Fig. 4 Retro-areolar breast cancer of the right breast treated by central quadrantectomy and Melon slice technique for reconstruction:
(A) preoperative mapping (B) immediate postoperative (C) 12 months postoperative views. The result was assessed by the patient as 4/5
(good result) and objectively by 6/10 (average result).
Fig. 5 Retro-areolar breast cancer of the right breast treated by central quadrantectomy and round block technique for reconstruction:
(A) preoperative mapping with injected patent blue traces for SLND, with two weeks lateral (B) and coronal (C) postoperative views. The
result was assessed by the patient as 5/5 (excellent result) and objectively by 10/10 (excellent result).
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Table 1 Different surgical procedures.
Procedure No. %
Oncoplastic procedure (n= 21a)
Latissimus dorsi ﬂap 6 28.6
Inferior pedicle ﬂap 8 38.1
Grisotti procedureb 3 14.3
Melon slice techniquec 2 9.5
Round block techniqued 2 9.5
Nipple resection 19 90.5
Axillary management (n= 21a)
SLNDd 1 4.8
ALND 20 95.2
SLND: sentinel lymph node detection; ALND: axillary lymph node
dissection.
a One case of inferior pedicle ﬂap was completed to modiﬁed
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All patients completed their treatment and follow-up plans.
Nineteen (95.0%) patients received postoperative breast radio-
therapy, while 9/20 (45.0%) and 3/20 (15.0%) received adju-
vant chemotherapy or hormonal therapy, respectively, and
only 8/20 (40.0%) patients received both therapies. During a
median follow-up period of 14.89 months, neither local nor
distant metastasis, were detected. We report no deaths among
our patients.
Cosmetic outcome
The postoperative cosmetic result evaluated by the patients
was excellent in 6/20 patients (30.0%), good in 11/20 patients
(55.0%), fair in 3/20 (15.0%) with neither poor nor bad results,
with an overall mean of 4.0 ± 0.5 equivalent to 80%
satisfaction.
The postoperative cosmetic result as evaluated by 3 profes-
sional investigators on a 10 point scale was marked 10 in 1/20
patients (5.0%), 9 in 1/20 patients (5.0%), 8 in 7/20 patients
(35.0%), 7 in 5/20 (25.0%), 6 in 4/20 (20.0%), and 5 in 1/20
(5.0%), and 4 in 1/20 (5.0%), with a mean of 7.2 ± 1.35 equiv-
alent to 72% satisfaction. Patient dissatisfaction was explained
by scar presence, keloid scar, minimal breast shape asymmetry
and NAC absence or asymmetry. Objective was dissatisfaction
based by absence of NAC, keloid scar, minimal breast shape
asymmetry, and scar retraction.
Discussion
Patients with centrally located breast cancer (CLBC) account
for 5–20% of breast cancer cases and, for a long time, they
have been denied breast conservation surgery (BCS) and
instead been conventionally treated with mastectomy [15].
The high incidence of NAC involvement associated with these
tumors necessitates, usually, NAC resection together with an
adequate safety margin around the tumor, which has yielded
non-satisfactory cosmetic results [30]. In cases where NAC
was not involved, Flierl and Hanker [31] reported satisfactoryresults using central segmental mastectomy with preservation
of NAC and volume displacement, however, they also noticed
that NAC distortion was a very common cosmetic deformity.
The mean tumor diameter in this study was 2.9 ± 0.95 cm,
conferring with the reported Egyptian patients being 2.9 cm
[32]. The incidence of ILC was 10% comparable to the
reported incidence in Egypt as 6–7% [32]. The incidence of
positive axillary nodes was 65.0%, which is almost equal to
the reported incidence with breast cancer in Egypt 63% [33].
In this study we report 25% complicated cases, this is more
than other authors who reported 5–26% [13,34,12,35]. How-
ever, since most of these were just seroma, only 2 (10%) of
our patients had a delay in their adjuvant treatment for two
and four weeks, respectively.
In this study we reported one case of involved margin, this
is lower than other authors who reported up to 13.1%, which
can be explained by our large safety margin with a mean of
2.5 ± 0.83 cm which was insured in this study, and the better
histology that we encountered, with only one case of DCIS, a
major cause for involved margins [13]. Nevertheless, we have
chosen to re-operate our single patient with immediate total
reconstruction rather than adopting a conservative pathway
as did other authors [13].
In this study, we did not report any cases of local recur-
rences or distant metastasis, as usually reported by other
authors [13], this can be explained by the small number dic-
tated by the relative rarity of the CLBC, not exceeding 9%
of breast cancer cases [36]. Another cause might be the short
time of follow up, which actually was not one of the main
intentions of this effort. However, it worth mentioning in this
context that, other authors reported in extended series of 298
patients treated with OBS, 5-year recurrence-free and overall
survival rates of 93.7% and 94.6%, respectively [12].
Despite the resultant smaller volume following OBS, the
shape and the form of the breast is preserved. Most patients
do not request, or require, further surgery for cosmesis. The
techniques used mainly involve direct incisions. These scars
are rarely conspicuous because they become less visible after
radiotherapy; however, they are much longer than usual lump-
ectomy scars, and patients should be warned of this drawback
[13].
Only one of our patients agreed to undergo contra-lateral
mammoplasty for symmetrization, this was true whether this
option was offered synchronously with tumor ablation, for
fear of bilateral scarring and disﬁgurement, or even when it
was offered as a delayed procedure, most probably because
of the patients being tired from previous surgery and long
exhausting radiotherapy and chemotherapy being reluctant
to go through an additional ‘‘disputable’’ surgical intervention,
this is similar to what has been reported by other Egyptian col-
leagues [37].
Moreover, all patients were reluctant to undergo a NAC
reconstruction, though it is a much simpler procedure if com-
pared to contralateral symmetrization, this was also reported
by other not only Egyptian colleagues, but also Italian authors
[38], which insinuates that simple preservation of the breast
mound for a feminine body contour is the most essential
requirement for women, especially in relatively conservative
societies.
In this study, the cosmetic result was evaluated by patients
as excellent in 6/20 (30.0%) patients, good in 11/20 (55.0%)
patients, with an overall mean of 4.0 ± 0.5 equivalent to
208 A. Moustafa, I. Fakhr80% satisfaction. This is worse than the results reported by
other authors who reported excellent up to 80%, and good
up to 20% [39,40]. This can be explained by the fact that all
patients, although they were reluctant to undergo a NAC
reconstruction, considered its absence as a defect in the overall
cosmetic outcome. On the contrary, the objective evaluation
had a mean of 7.2 ± 1.35 equivalent to 72% satisfaction,
which was even slightly lower than the cosmetic result, when
graded by independent observers. This relative higher satisfac-
tion rate by patients, than professionals, was commonly
reported by other authors, and may not necessarily be based
on objective criteria but due to the fact that breast cancer
patients have an initial fear of losing their breast, hence their
satisfaction by its simple preservation. [41].
Conclusion
Multiple oncoplastic breast surgery techniques can be used for
the resection of CLBC with satisfying cosmetic outcomes,
however, these techniques need tedious training, and good
matching with both, the tumor location, and the size of the
breast.
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